1. Home
  2. PFX vs CSBR Comparison

PFX vs CSBR Comparison

Compare PFX & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFX
  • CSBR
  • Stock Information
  • Founded
  • PFX 2010
  • CSBR 1985
  • Country
  • PFX United States
  • CSBR United States
  • Employees
  • PFX N/A
  • CSBR N/A
  • Industry
  • PFX Finance: Consumer Services
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PFX Finance
  • CSBR Health Care
  • Exchange
  • PFX Nasdaq
  • CSBR Nasdaq
  • Market Cap
  • PFX 99.7M
  • CSBR 111.4M
  • IPO Year
  • PFX N/A
  • CSBR 1986
  • Fundamental
  • Price
  • PFX $49.79
  • CSBR $7.77
  • Analyst Decision
  • PFX
  • CSBR Strong Buy
  • Analyst Count
  • PFX 0
  • CSBR 1
  • Target Price
  • PFX N/A
  • CSBR $12.00
  • AVG Volume (30 Days)
  • PFX 2.1K
  • CSBR 27.6K
  • Earning Date
  • PFX 08-05-2025
  • CSBR 09-10-2025
  • Dividend Yield
  • PFX 2.89%
  • CSBR N/A
  • EPS Growth
  • PFX N/A
  • CSBR N/A
  • EPS
  • PFX 5.09
  • CSBR 0.46
  • Revenue
  • PFX $24,036,577.00
  • CSBR $58,591,000.00
  • Revenue This Year
  • PFX $10.51
  • CSBR $15.11
  • Revenue Next Year
  • PFX N/A
  • CSBR $7.80
  • P/E Ratio
  • PFX $9.72
  • CSBR $17.16
  • Revenue Growth
  • PFX 15.02
  • CSBR 19.03
  • 52 Week Low
  • PFX $44.56
  • CSBR $3.60
  • 52 Week High
  • PFX $57.40
  • CSBR $11.99
  • Technical
  • Relative Strength Index (RSI)
  • PFX 55.10
  • CSBR 54.86
  • Support Level
  • PFX $48.90
  • CSBR $7.77
  • Resistance Level
  • PFX $53.59
  • CSBR $9.63
  • Average True Range (ATR)
  • PFX 0.59
  • CSBR 0.65
  • MACD
  • PFX -0.04
  • CSBR -0.01
  • Stochastic Oscillator
  • PFX 36.88
  • CSBR 44.53

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: